Articles tagged with “pharma-ai”

Analyze Bristol Myers Squibb's deployment of Anthropic Claude to 30,000 employees. Examine agentic AI enterprise strategies and pharma change management.

Examine LLM security risks in pharma, including prompt injection and data exfiltration. Review red teaming methods and GxP risk assessments for regulated AI.

Analyze IQVIA's deployment of 192 pharma AI agents across 64 use cases. Learn how top life sciences CIOs benchmark enterprise AI adoption and ROI in 2026.

Examine the impact of Novartis CEO Vas Narasimhan joining Anthropic's board. This report analyzes pharma AI governance, healthcare regulations, and drug R&D.

Analyze the $1B Merck and Google Cloud partnership. This report explains how agentic AI and Gemini Enterprise apply to pharmaceutical R&D and data workflows.

Examine the $50M GSK-Noetik agreement licensing AI foundation models for oncology. Learn how spatial biology and virtual cells advance R&D and drug discovery.

Analyze Insilico Medicine's Pharma.AI platform for AI drug discovery. Learn how PandaOmics, Chemistry42, and MMAI Gym integrate for target and molecule design.

Examine the 2026 AI digital health landscape. Learn how Big Tech, pharmaceutical companies, and startups compete and collaborate in AI-powered healthcare.

Explore how to structure a Pharma AI Center of Excellence. This guide covers organizational design, hub-and-spoke models, AI governance, and enterprise scaling.

Examine 2026 AI infrastructure investments in pharmaceutical R&D. This report details the Lilly-NVIDIA lab, Earendil funding, and GPU compute deployments.

Examine how pharma organizations deploy private LLMs using air-gapped AI architecture to maintain data sovereignty and comply with FDA and GDPR regulations.

Examine how the EU Digital Omnibus impacts pharma AI and medical device compliance. Review AI Act timeline extensions, MDR integration, and GDPR data updates.

Learn how pharma companies transition to AI operating models. Compare Moderna's workforce education, Sanofi's enterprise integration, and BMS's predictive R&D.

Examine why enterprise AI demands custom infrastructure, compute, and data pipelines over generic chat apps, featuring the Eli Lilly supercomputer case study.

Learn why 95% of pharma AI pilots fail to reach production. This guide explains PoC failure causes, data integration challenges, and strategies for scaling.

Explore pharma AI change management and organizational readiness strategies. Understand how life science companies build AI literacy to address skills gaps.

Learn how agentic AI in pharma transitions from pilot stages to production. Explore autonomous multi-agent systems, clinical use cases, and regulatory impacts.

Examine why most pharma AI pilots fail to reach production. This report analyzes data fragmentation, governance issues, and building scalable data foundations.

Learn to validate AI vendor claims in pharma. This due diligence checklist covers GxP compliance, data security, and model performance verification methods.

Review the ISPE GAMP AI Guide for validating machine learning in GxP. Learn the risk-based framework for data integrity and regulatory compliance.

Learn to deploy private LLMs in pharma. This guide covers compliant architecture, including on-premise & cloud, and navigating HIPAA, GxP, and FDA regulations.

A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, vendor evaluation criteria, and the emerging foundation model licensing trend. Updated April 2026 with EU AI Act compliance deadlines, FDA-EMA joint guidance, and latest pharma AI partnerships.

A technical overview of Claude Opus 4.5 and 4.6, state-of-the-art AI models for coding. Learn their capabilities for software development in healthcare and pharma. Updated February 2026.